Wockhardt is currently trading at Rs. 234.40, up by 3.40 points or 1.47% from its previous closing of Rs. 231.00 on the BSE. The scrip opened at Rs. 234.90 and has touched a high and low of Rs. 236.20 and Rs. 231.85 respectively. So far 17787 shares were traded on the counter. The BSE group … Read more
Wockhardt has received permission from the Central Drugs Standard Control Organization (CDSCO) to export up to 80 million doses of Sputnik Light and up to 20 million doses of Sputnik V Component I vaccine. The company’s Bulk vaccine and Fill-Finish manufacturing facilities at Waluj and Shendra, Aurangabad respectively were jointly inspected and approved by Drug … Read more
Wockhardt has reported results for second quarter ended September 30, 2018. The company has reported a fall of 79.86% in its net profit at Rs 5.10 crore for the quarter under review as compared to Rs 25.32 crore for the same quarter in the previous year. However, total income of the company increased by 6.95% … Read more
Wockhardt has received approval for raising of funds through issuance of Non-Convertible Debentures (NCDs)/ Bonds (secured/ unsecured) on private placement basis up to an aggregate amount not exceeding Rs 1,800 crore. The Board of Directors of the company at its meeting held on November 10, 2018 has approved the same. Wockhardt is one of the … Read more
